Mission

The goals of the Molecular Imaging (MI) Program include the development and testing of new imaging methods ranging from preclinical work on the synthesis of new probes and development of new devices to the clinical evaluation of imaging approaches to assess cancer risk, detect cancer, guide treatment and monitor therapy. These imaging methods are aimed at improving our understanding of cancer physiology and providing for the integration of these findings to ultimately improve the assessment of cancer and its treatment. To achieve these goals we have two themes. 

Scientific Themes

  • Theme 1. Synthesis of new imaging agents for metabolism and drug pharmacodynamics
  • Theme 2. Implement and test new imaging agents and methods for risk assessment, detection, guidance and assessment of the response to therapy
  • Theme 3. Develop and test novel instrumentation for molecular imaging

Program Activities

The MI Program works to bring investigators together to expand collaborative activities with members of our program and other programs through:

  • Monthly program meetings which include speakers from within the MI Program, speakers from related disciplines and invited outside speakers. 
  • Joint meetings or mini-retreats with other programs to highlight particular areas of collaboration. 
  • Yearly retreats are held for the program to further foster collaboration among members
  • Organization of working groups to evaluate joint projects including multi-investigator pilot projects, protocols, and grants. 

Program Leaders

  • Nerissa Viola, Ph.D.

    Leader, Molecular Imaging Program
    Karmanos Cancer Institute
    Wayne State University School of Medicine

  • Anthony Shields, M.D., Ph.D.

    Co-Leader, Molecular Imaging Program
    Karmanos Cancer Institute
    Wayne State University School of Medicine

The Latest From Karmanos Cancer Institute

News

Karmanos Cancer Institute Receives 2025 Women’s Choice Awards® for Cancer Care, Mammogram Imaging, Minimally Invasive Surgery and Patient Experience

The Barbara Ann Karmanos Cancer Institute has been named one of America’s 2025 Best Hospitals for Cancer Care, Mammogram Imaging, Minimally Invasi...

Read More

A Melody of Courage: Sierra’s Cancer Journey After Being Diagnosed with Hodgkin Lymphoma

From a young age, music has been a big part of Sierra Watson’s life. In seventh grade, she started playing the bassoon. It became a passion of her...

Read More

IN THE NEWS – NSCLC: Racial and Socioeconomic Disparities in Survival Rates

MedPage Today Dipesh Uprety, M.D., FACP , medical oncologist, member of the  Phase I Clinical Trials  and  Thoracic Oncology  ...

Read More
News

WDET | Cancer Warning Label on Alcohol

Listen Now

WDET | Scholarship Program Aims to Encourage More Diversity in Clinical Trials

Listen Now

101 WRIF | Lung Cancer Awareness

Listen Now